Exhaled Nitric Oxide fraction in asthma and obstructive sleep apnea among children at high altitudes. A cross-sectional study
Sleep Medicine · 2024
DOI: 10.1016/j.sleep.2024.05.023 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Sleep Medicine, 2024. Verfasst von Oscar Camilo Pantoja-Gomez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de La Sabana, Colombia; Fundación Neumologica Colombiana, Colombia. Electronic address: oscarpago@unisabana.edu.co. Hauptthemen laut MEDLINE: Asthma, Sleep Apnea, Obstructive, Altitude, Nitric Oxide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
INTRODUCTION: Exhaled nitric oxide fraction (FeNO) is employed for the diagnosis and phenotyping of asthma as an inflammatory biomarker of the airway. Limited evidence exists regarding its behavior in the presence of asthma and obstructive sleep apnea (OSA). Our objective was to determine whether FeNO levels are associated with the severity of OSA or the coexistence of asthma and OSA in residents at high altitudes. MATERIALS AND METHODS: Observational, analytical, cross-sectional study in children aged 5-16 years residing at 2600 m above sea level treated at a Sleep Study Center between 2019 and 2021. We conducted a medical history, polysomnogram, and measurement of FeNO levels. The children were categorized into four groups: OSA, asthma, asthma with OSA, and controls (without asthma or OSA). FeNO levels among the groups were compared using the Kruskal-Wallis test, and correlations were explored using the Spearman correlation coefficient. Analyses considered statistical significance at a two-tailed p-value 20 ppb and FeNO >35 ppb (>75th percentile). In the adjusted model, a significant association was observed between asthma and FeNO levels. CONCLUSIONS: Our findings suggest that FeNO measurements in children would not allow establishing this biomarker as part of the diagnosis of OSA. However, these findings may be related to high altitude.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidad de La Sabana, Colombia; Fundación Neumologica Colombiana, Colombia. Electronic address: oscarpago@unisabana.edu.co.
- Universidad de La Sabana, Colombia; Fundación Neumologica Colombiana, Colombia.
- Fundación Neumologica Colombiana, Colombia.
- The George Washington University School of Medicine and Health Sciences, USA; Children's National Hospital, USA.
Zitieren
APA
Pantoja-Gomez, O. C., Agudelo-Agudelo, J., Duenas-Mesa, E., Proaños, J., Escamilla-Gil, M. I., Suarez, M. R., Nino, G., & Giraldo, L. F. (2024). Exhaled Nitric Oxide fraction in asthma and obstructive sleep apnea among children at high altitudes. A cross-sectional study. Sleep Medicine. https://doi.org/10.1016/j.sleep.2024.05.023
Vancouver
Pantoja-Gomez OC, Agudelo-Agudelo J, Duenas-Mesa E, Proaños J, Escamilla-Gil MI, Suarez MR, et al. Exhaled Nitric Oxide fraction in asthma and obstructive sleep apnea among children at high altitudes. A cross-sectional study. Sleep Medicine. 2024. doi:10.1016/j.sleep.2024.05.023
BibTeX
@article{PantojaGomez2024,
author = {Pantoja-Gomez, Oscar Camilo and Agudelo-Agudelo, Juanita and Duenas-Mesa, Elida and Proaños, Juliana and Escamilla-Gil, Maria Isabel and Suarez, Miguel Ricardo and Nino, Gustavo and Giraldo, Luis Fernando},
title = {Exhaled Nitric Oxide fraction in asthma and obstructive sleep apnea among children at high altitudes. A cross-sectional study},
journal = {Sleep Medicine},
year = {2024},
doi = {10.1016/j.sleep.2024.05.023}
}
EUVIMED